Altimmune, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Altimmune, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Altimmune, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.92M, a 2.84% increase year-over-year.
- Altimmune, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $8.41M, a 21.3% increase year-over-year.
- Altimmune, Inc. annual Nonoperating Income (Expense) for 2023 was $7.48M, a 164% increase from 2022.
- Altimmune, Inc. annual Nonoperating Income (Expense) for 2022 was $2.83M.
- Altimmune, Inc. annual Nonoperating Income (Expense) for 2021 was -$176K, a 152% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)